ID   S38A3_RAT               Reviewed;         504 AA.
AC   Q9JHZ9; Q66HS0;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-OCT-2024, entry version 132.
DE   RecName: Full=Sodium-coupled neutral amino acid transporter 3 {ECO:0000305};
DE   AltName: Full=N-system amino acid transporter 1;
DE   AltName: Full=Na(+)-coupled neutral amino acid transporter 3;
DE   AltName: Full=Solute carrier family 38 member 3;
DE   AltName: Full=System N amino acid transporter 1;
GN   Name=Slc38a3 {ECO:0000312|RGD:628620}; Synonyms=Snat3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAF81797.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain {ECO:0000269|PubMed:10619430};
RX   PubMed=10619430; DOI=10.1016/s0092-8674(00)81674-8;
RA   Chaudhry F.A., Reimer R.J., Krizaj D., Barber D., Storm-Mathisen J.,
RA   Copenhagen D.R., Edwards R.H.;
RT   "Molecular analysis of system N suggests novel physiological roles in
RT   nitrogen metabolism and synaptic transmission.";
RL   Cell 99:769-780(1999).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Skeletal muscle {ECO:0000269|PubMed:10823827};
RX   PubMed=10823827; DOI=10.1074/jbc.m002282200;
RA   Fei Y.-J., Sugawara M., Nakanishi T., Huang W., Wang H., Prasad P.D.,
RA   Leibach F.H., Ganapathy V.;
RT   "Primary structure, genomic organization, and functional and electrogenic
RT   characteristics of human system N 1, a Na+- and H+-coupled glutamine
RT   transporter.";
RL   J. Biol. Chem. 275:23707-23717(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=11742981; DOI=10.1093/emboj/20.24.7041;
RA   Chaudhry F.A., Krizaj D., Larsson P., Reimer R.J., Wreden C.,
RA   Storm-Mathisen J., Copenhagen D., Kavanaugh M., Edwards R.H.;
RT   "Coupled and uncoupled proton movement by amino acid transport system N.";
RL   EMBO J. 20:7041-7051(2001).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=11850497; DOI=10.1113/jphysiol.2001.013303;
RA   Broeer A., Albers A., Setiawan I., Edwards R.H., Chaudhry F.A., Lang F.,
RA   Wagner C.A., Broeer S.;
RT   "Regulation of the glutamine transporter SN1 by extracellular pH and
RT   intracellular sodium ions.";
RL   J. Physiol. (Lond.) 539:3-14(2002).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16249471; DOI=10.1167/iovs.05-0488;
RA   Umapathy N.S., Li W., Mysona B.A., Smith S.B., Ganapathy V.;
RT   "Expression and function of glutamine transporters SN1 (SNAT3) and SN2
RT   (SNAT5) in retinal Mueller cells.";
RL   Invest. Ophthalmol. Vis. Sci. 46:3980-3987(2005).
RN   [7]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=15716335; DOI=10.1681/asn.2004060433;
RA   Solbu T.T., Boulland J.L., Zahid W., Lyamouri Bredahl M.K.,
RA   Amiry-Moghaddam M., Storm-Mathisen J., Roberg B.A., Chaudhry F.A.;
RT   "Induction and targeting of the glutamine transporter SN1 to the
RT   basolateral membranes of cortical kidney tubule cells during chronic
RT   metabolic acidosis suggest a role in pH regulation.";
RL   J. Am. Soc. Nephrol. 16:869-877(2005).
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASN-76; GLY-210; SER-215; HIS-300; THR-343; ARG-370 AND THR-380.
RX   PubMed=17148440; DOI=10.1074/jbc.m609452200;
RA   Schneider H.P., Broeer S., Broeer A., Deitmer J.W.;
RT   "Heterologous expression of the glutamine transporter SNAT3 in Xenopus
RT   oocytes is associated with four modes of uncoupled transport.";
RL   J. Biol. Chem. 282:3788-3798(2007).
RN   [9]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=17909850; DOI=10.1007/s00424-007-0351-y;
RA   Wendel C., Becker H.M., Deitmer J.W.;
RT   "The sodium-bicarbonate cotransporter NBCe1 supports glutamine efflux via
RT   SNAT3 (SLC38A3) co-expressed in Xenopus oocytes.";
RL   Pflugers Arch. 455:885-893(2008).
RN   [10]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, SITE, AND MUTAGENESIS
RP   OF ASN-76.
RX   PubMed=19596860; DOI=10.1074/jbc.m109.031013;
RA   Broeer S., Schneider H.P., Broeer A., Deitmer J.W.;
RT   "Mutation of asparagine 76 in the center of glutamine transporter SNAT3
RT   modulates substrate-induced conductances and Na+ binding.";
RL   J. Biol. Chem. 284:25823-25831(2009).
RN   [11]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-52, AND MUTAGENESIS OF THR-32; 51-SER--SER-53; SER-51; SER-52; SER-53
RP   AND THR-59.
RX   PubMed=21525297; DOI=10.1523/jneurosci.3694-10.2011;
RA   Nissen-Meyer L.S., Popescu M.C., Hamdani E.H., Chaudhry F.A.;
RT   "Protein kinase C-mediated phosphorylation of a single serine residue on
RT   the rat glial glutamine transporter SN1 governs its membrane trafficking.";
RL   J. Neurosci. 31:6565-6575(2011).
RN   [12]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=28272791; DOI=10.1002/glia.23133;
RA   Todd A.C., Marx M.C., Hulme S.R., Broeer S., Billups B.;
RT   "SNAT3-mediated glutamine transport in perisynaptic astrocytes in situ is
RT   regulated by intracellular sodium.";
RL   Glia 65:900-916(2017).
RN   [13]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=29561757; DOI=10.3390/ijms19040924;
RA   Dong W., Todd A.C., Broeer A., Hulme S.R., Broeer S., Billups B.;
RT   "PKC-Mediated Modulation of Astrocyte SNAT3 Glutamine Transporter Function
RT   at Synapses in Situ.";
RL   Int. J. Mol. Sci. 19:0-0(2018).
CC   -!- FUNCTION: Symporter that cotransports specific neutral amino acids and
CC       sodium ions, coupled to an H(+) antiporter activity (PubMed:10619430,
CC       PubMed:10823827, PubMed:11742981, PubMed:11850497, PubMed:16249471,
CC       PubMed:17148440, PubMed:19596860, PubMed:21525297, PubMed:28272791,
CC       PubMed:29561757). Mainly participates in the glutamate-GABA-glutamine
CC       cycle in brain where it transports L-glutamine from astrocytes in the
CC       intercellular space for the replenishment of both neurotransmitters
CC       glutamate and gamma-aminobutyric acid (GABA) in neurons
CC       (PubMed:10619430, PubMed:28272791, PubMed:29561757). Also functions as
CC       the major influx transporter in ganglion cells mediating the uptake of
CC       glutamine (By similarity). The transport activity is specific for L-
CC       glutamine, L-histidine and L-asparagine (PubMed:10619430,
CC       PubMed:10823827, PubMed:11742981, PubMed:11850497, PubMed:16249471,
CC       PubMed:17148440, PubMed:19596860, PubMed:21525297, PubMed:28272791,
CC       PubMed:29561757). The transport is electroneutral coupled to the
CC       cotransport of 1 Na(+) and the antiport of 1 H(+), pH dependent,
CC       saturable, Li(+) tolerant and functions in both direction depending on
CC       the concentration gradients of its substrates and cotransported ions
CC       (PubMed:10619430, PubMed:10823827, PubMed:11742981, PubMed:11850497,
CC       PubMed:16249471, PubMed:17148440, PubMed:17909850, PubMed:19596860,
CC       PubMed:28272791). Also mediates an amino acid-gated H(+) conductance
CC       that is not stoichiometrically coupled to the amino acid transport but
CC       which influences the ionic gradients that drive the amino acid
CC       transport (PubMed:11742981). In addition, may play a role in nitrogen
CC       metabolism, amino acid homeostasis, glucose metabolism and renal
CC       ammoniagenesis (By similarity). {ECO:0000250|UniProtKB:Q9DCP2,
CC       ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:10823827,
CC       ECO:0000269|PubMed:11742981, ECO:0000269|PubMed:11850497,
CC       ECO:0000269|PubMed:16249471, ECO:0000269|PubMed:17148440,
CC       ECO:0000269|PubMed:17909850, ECO:0000269|PubMed:19596860,
CC       ECO:0000269|PubMed:21525297, ECO:0000269|PubMed:28272791,
CC       ECO:0000269|PubMed:29561757}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(in) + L-glutamine(out) + Na(+)(out) = H(+)(out) + L-
CC         glutamine(in) + Na(+)(in); Xref=Rhea:RHEA:71127, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:58359;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:11742981,
CC         ECO:0000269|PubMed:11850497, ECO:0000269|PubMed:16249471,
CC         ECO:0000269|PubMed:17148440, ECO:0000269|PubMed:19596860,
CC         ECO:0000269|PubMed:21525297, ECO:0000269|PubMed:28272791,
CC         ECO:0000269|PubMed:29561757};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71128;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:11742981,
CC         ECO:0000269|PubMed:11850497, ECO:0000269|PubMed:16249471,
CC         ECO:0000269|PubMed:17148440, ECO:0000269|PubMed:28272791,
CC         ECO:0000269|PubMed:29561757, ECO:0000305|PubMed:21525297};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71129;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:11850497,
CC         ECO:0000269|PubMed:28272791, ECO:0000269|PubMed:29561757};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(in) + L-asparagine(out) + Na(+)(out) = H(+)(out) + L-
CC         asparagine(in) + Na(+)(in); Xref=Rhea:RHEA:71131, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:58048;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:10823827,
CC         ECO:0000269|PubMed:11742981, ECO:0000269|PubMed:19596860,
CC         ECO:0000269|PubMed:21525297, ECO:0000269|PubMed:28272791};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71132;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:11742981,
CC         ECO:0000269|PubMed:28272791, ECO:0000305|PubMed:10823827,
CC         ECO:0000305|PubMed:21525297};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71133;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:28272791};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(in) + L-histidine(out) + Na(+)(out) = H(+)(out) + L-
CC         histidine(in) + Na(+)(in); Xref=Rhea:RHEA:71135, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:57595;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:11742981,
CC         ECO:0000269|PubMed:28272791};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71136;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:28272791,
CC         ECO:0000305|PubMed:11742981};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71137;
CC         Evidence={ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:28272791};
CC   -!- ACTIVITY REGULATION: L-glutamine efflux and L-glutamine uptake are
CC       regulated by CO2/HCO3(-) through SLC4A4 leading to modulation of
CC       cytosolic pH and Na(+)concentration. {ECO:0000269|PubMed:17909850}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.1 mM for L-glutamine {ECO:0000269|PubMed:10619430};
CC         KM=1.5 mM for L-glutamine (at pH 7.4) {ECO:0000269|PubMed:11850497};
CC         KM=31 mM for sodium ion (at pH 7) {ECO:0000269|PubMed:11850497};
CC         KM=38 mM for sodium ion (at pH 6) {ECO:0000269|PubMed:11850497};
CC         KM=6.3 mM for sodium ion (at pH 8) {ECO:0000269|PubMed:11850497};
CC         KM=3.3 mM for L-glutamine (at pH 6) {ECO:0000269|PubMed:11850497};
CC         KM=2.4 mM for L-glutamine (at pH 7) {ECO:0000269|PubMed:11850497};
CC         KM=1.6 mM for L-glutamine (at pH 8) {ECO:0000269|PubMed:11850497};
CC       pH dependence:
CC         Optimum pH is 8. {ECO:0000269|PubMed:16249471};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10619430,
CC       ECO:0000269|PubMed:17148440, ECO:0000269|PubMed:19596860,
CC       ECO:0000269|PubMed:21525297, ECO:0000269|PubMed:29561757}; Multi-pass
CC       membrane protein {ECO:0000255}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:15716335}. Note=The localization appears to be
CC       basolateral in the plasma membrane of hepatocytes surrounding the
CC       central vein. Localized at the cerebrospinal fluid (CSF)-facing
CC       membrane of the choroid plexus epithelial cells. In astrocytes, the
CC       localization at cell membrane is decreased by ammonia through the PKC
CC       signaling. Expressed in both luminal and abluminal plasma membranes of
CC       larger microvessels and blood brain barrier (BBB) capillaries (By
CC       similarity). Restricted to the basolateral membranes of S3 segment
CC       cells of the proximal tubules (PubMed:15716335).
CC       {ECO:0000250|UniProtKB:Q9DCP2, ECO:0000269|PubMed:15716335}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver (PubMed:10619430).
CC       Expressed in skeletal muscle. Expressed in kidney, heart and brain
CC       (PubMed:10619430). Not detected in gut, lung or spleen
CC       (PubMed:10619430). Expressed ubiquitously in hepatocytes in liver
CC       whereas in kidney expression is restricted to the medulla
CC       (PubMed:10619430). Within brain, expressed in glial cells
CC       (PubMed:10619430). In the cerebellum, expressed on Bergmann glial
CC       fibers in the molecular layer and astrocytes in the granule layer
CC       (PubMed:10619430). Expressed in brain kidney and liver (at protein
CC       level) (PubMed:15716335). In the adult kidney, highly expressed in the
CC       outer strip of the outer medulla and medullary rays penetrating into
CC       the kidney cortex (at protein level) (PubMed:15716335).
CC       {ECO:0000269|PubMed:10619430, ECO:0000269|PubMed:10823827,
CC       ECO:0000269|PubMed:15716335}.
CC   -!- INDUCTION: Induced by chronic metabolic acidosis (CMA).
CC       {ECO:0000269|PubMed:15716335}.
CC   -!- PTM: Phosphorylation at Ser-52 induces internalization and
CC       sequestration into an intracellular reservoir (PubMed:21525297,
CC       PubMed:29561757). During dephosphorylation by protein phosphatases, can
CC       recycle back to the plasma membrane and regain activity. Prolonged
CC       phosphorylation results in its degradation (PubMed:21525297).
CC       {ECO:0000269|PubMed:21525297, ECO:0000269|PubMed:29561757}.
CC   -!- SIMILARITY: Belongs to the amino acid/polyamine transporter 2 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Fei et al (PMID:10823827) shows that the transport process is
CC       electrogenic with a Na(+):L-glutamine stoichiometry of 2:1, contrary to
CC       the conclusions of Chaudhry et al (PMID:10619430) who finds that the
CC       transport is electroneutral with a Na(+):L-glutamine stoichiometry of
CC       1:1. Chaudhry et al (PMID=11742981) shows that this electrogenic
CC       transport describes by Fei et al (PMID=10823827) would correspond to an
CC       amino acid-gated H(+) conductance that is not stoichiometrically
CC       coupled to the amino acid transport but which influences the ionic
CC       gradients that drive the amino acid transport.
CC       {ECO:0000305|PubMed:10823827, ECO:0000305|PubMed:11742981}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF273025; AAF81797.1; -; mRNA.
DR   EMBL; BC081717; AAH81717.1; -; mRNA.
DR   RefSeq; NP_665719.1; NM_145776.1.
DR   AlphaFoldDB; Q9JHZ9; -.
DR   SMR; Q9JHZ9; -.
DR   BioGRID; 251668; 1.
DR   STRING; 10116.ENSRNOP00000023623; -.
DR   GlyCosmos; Q9JHZ9; 4 sites, No reported glycans.
DR   GlyGen; Q9JHZ9; 4 sites.
DR   iPTMnet; Q9JHZ9; -.
DR   PhosphoSitePlus; Q9JHZ9; -.
DR   PaxDb; 10116-ENSRNOP00000023623; -.
DR   Ensembl; ENSRNOT00000023623.8; ENSRNOP00000023623.4; ENSRNOG00000016827.8.
DR   Ensembl; ENSRNOT00055022921; ENSRNOP00055018583; ENSRNOG00055013368.
DR   Ensembl; ENSRNOT00060051083; ENSRNOP00060042496; ENSRNOG00060029424.
DR   Ensembl; ENSRNOT00065013218; ENSRNOP00065009785; ENSRNOG00065008326.
DR   GeneID; 252919; -.
DR   KEGG; rno:252919; -.
DR   UCSC; RGD:628620; rat.
DR   AGR; RGD:628620; -.
DR   CTD; 10991; -.
DR   RGD; 628620; Slc38a3.
DR   eggNOG; KOG1305; Eukaryota.
DR   GeneTree; ENSGT00940000157127; -.
DR   HOGENOM; CLU_009020_0_2_1; -.
DR   InParanoid; Q9JHZ9; -.
DR   OMA; ETMPYWK; -.
DR   OrthoDB; 935269at2759; -.
DR   PhylomeDB; Q9JHZ9; -.
DR   TreeFam; TF328787; -.
DR   Reactome; R-RNO-352230; Amino acid transport across the plasma membrane.
DR   PRO; PR:Q9JHZ9; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000016827; Expressed in liver and 18 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015180; F:L-alanine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015182; F:L-asparagine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0140831; F:L-asparagine, sodium:proton antiporter activity; IDA:UniProtKB.
DR   GO; GO:0015186; F:L-glutamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0140830; F:L-glutamine, sodium:proton antiporter activity; IDA:UniProtKB.
DR   GO; GO:0005290; F:L-histidine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0140832; F:L-histidine, sodium:proton antiporter activity; IDA:UniProtKB.
DR   GO; GO:0005295; F:neutral L-amino acid:sodium symporter activity; IDA:UniProtKB.
DR   GO; GO:0003333; P:amino acid transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006867; P:asparagine transport; IDA:UniProtKB.
DR   GO; GO:0051365; P:cellular response to potassium ion starvation; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0010585; P:glutamine secretion; IDA:UniProtKB.
DR   GO; GO:0006868; P:glutamine transport; IDA:UniProtKB.
DR   GO; GO:0015817; P:histidine transport; IDA:UniProtKB.
DR   GO; GO:0080144; P:intracellular amino acid homeostasis; ISS:UniProtKB.
DR   GO; GO:0015808; P:L-alanine transport; ISO:RGD.
DR   GO; GO:1902475; P:L-alpha-amino acid transmembrane transport; ISO:RGD.
DR   GO; GO:1903811; P:L-asparagine import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:1903803; P:L-glutamine import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:1903810; P:L-histidine import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:1902024; P:L-histidine transport; IDA:UniProtKB.
DR   GO; GO:2000487; P:positive regulation of glutamine transport; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   InterPro; IPR013057; AA_transpt_TM.
DR   PANTHER; PTHR22950; AMINO ACID TRANSPORTER; 1.
DR   PANTHER; PTHR22950:SF22; SODIUM-COUPLED NEUTRAL AMINO ACID TRANSPORTER 3; 1.
DR   Pfam; PF01490; Aa_trans; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Antiport; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Sodium; Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..504
FT                   /note="Sodium-coupled neutral amino acid transporter 3"
FT                   /id="PRO_0000093830"
FT   TRANSMEM        82..102
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        105..125
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        143..163
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        186..206
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        212..232
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        287..307
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        324..344
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        366..386
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        408..428
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        431..451
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        469..489
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   SITE            76
FT                   /note="Modulates L-glutamine-induced conductances and Na(+)
FT                   binding"
FT                   /evidence="ECO:0000269|PubMed:19596860"
FT   MOD_RES         52
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        247
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        323
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        239..275
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   MUTAGEN         32
FT                   /note="T->A: Does not affect phosphorylation by PKC."
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   MUTAGEN         51..53
FT                   /note="SSS->AAA: Loss of phosphorylation by PKC."
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   MUTAGEN         51
FT                   /note="S->A: Does not affect phosphorylation by PKC."
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   MUTAGEN         52
FT                   /note="S->A: Loss of phosphorylation by PKC. Reduces
FT                   glutamine uptake upon phorbol-12-myristate-13-acetate (PMA)
FT                   stimulation."
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   MUTAGEN         53
FT                   /note="S->A: Does not affect phosphorylation by PKC."
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   MUTAGEN         59
FT                   /note="T->A: Does not affect phosphorylation by PKC."
FT                   /evidence="ECO:0000269|PubMed:21525297"
FT   MUTAGEN         76
FT                   /note="N->D: Abolishes L-glutamine transport activity.
FT                   Induces a chloride transport. Increases the alkali-induced
FT                   substrate-independent conductance. Does not affect cell
FT                   membrane localization."
FT                   /evidence="ECO:0000269|PubMed:19596860"
FT   MUTAGEN         76
FT                   /note="N->E: Abolishes L-glutamine transport activity.
FT                   Induces a chloride transport. Increases the alkali-induced
FT                   substrate-independent conductance. Does not affect cell
FT                   membrane localization."
FT                   /evidence="ECO:0000269|PubMed:19596860"
FT   MUTAGEN         76
FT                   /note="N->H: Abolishes L-glutamine transport activity.
FT                   Inhibits asparagine transport activity. Increases the
FT                   alkali-induced substrate-independent conductance.
FT                   Significantly slow proton antiport activity. Affects cell
FT                   membrane localization."
FT                   /evidence="ECO:0000269|PubMed:17148440,
FT                   ECO:0000269|PubMed:19596860"
FT   MUTAGEN         76
FT                   /note="N->Q: Abolishes glutamine transport activity.
FT                   Increases the alkali-induced substrate-independent
FT                   conductance. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:19596860"
FT   MUTAGEN         76
FT                   /note="N->S: Abolishes glutamine transport
FT                   activity.Increases the alkali-induced substrate-independent
FT                   conductance. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:19596860"
FT   MUTAGEN         210
FT                   /note="G->A: Does not affect L-glutamine transport
FT                   activity. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:17148440"
FT   MUTAGEN         215
FT                   /note="S->A: Does not affect L-glutamine transport
FT                   activity. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:17148440"
FT   MUTAGEN         300
FT                   /note="H->Q: Does not affect L-glutamine transport
FT                   activity. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:17148440"
FT   MUTAGEN         343
FT                   /note="T->A: Does not affect L-glutamine transport
FT                   activity. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:17148440"
FT   MUTAGEN         370
FT                   /note="R->Q: Does not affect L-glutamine transport
FT                   activity. Does not affect cell membrane localization."
FT                   /evidence="ECO:0000269|PubMed:17148440"
FT   MUTAGEN         380
FT                   /note="T->A: Significantly decreases L-glutamine transport
FT                   activity. Does not affect cell membrane localization.
FT                   Removes the cation conductance at pH 7.4. Does not affect
FT                   the proton conductance at pH 8.4. Significantly dereases
FT                   transport activity with LiCl."
FT                   /evidence="ECO:0000269|PubMed:17148440"
SQ   SEQUENCE   504 AA;  55637 MW;  D8C19AED34A791DD CRC64;
     MEIPRQTEMV ELVPNGKHLE GLLPVGMPTA DTQRAEDAQH CGEGKGFLQQ SSSKEPHFTD
     FEGKTSFGMS VFNLSNAIMG SGILGLAYAM ANTGIILFLF LLTAVALLSS YSIHLLLKSS
     GIVGIRAYEQ LGYRAFGTPG KLAAALAITL QNIGAMSSYL YIIKSELPLV IQTFLNLEKP
     TPVWYMDGNY LVILVSVIII LPLALMRQLG YLGYSSGFSL SCMVFFLIAV IYKKFQVPCP
     LAHNLVNATG NFSHMVVVEE KSQLQSEPDT AEAFCTPSYF TLNSQTAYTI PIMAFAFVCH
     PEVLPIYTEL KDPSKRKMQH ISNLSIAVMY VMYFLAALFG YLTFYDGVES ELLHTYSKVD
     PFDVLILCVR VAVLIAVTLT VPIVLFPVRR AIQQMLFQNQ EFSWLRHVLI ATGLLTCINL
     LVIFAPNILG IFGIIGATSA PCLIFIFPAI FYFRIMPTEK EPVRSTPKIL ALCFAAVGFL
     LMTMSLSFII TDWVSGTSQH GGNH
//
